Glucose utilization in a patient with hepatoma and hypoglycemia. Assessment by a positron emission tomography.
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Tumor glucose use in patients with non-islet-cell tumors has been difficult to measure, particularly in hepatoma, because of hepatic involvement by neoplasm. We studied a patient with nonhepatic recurrence of hepatoma after successful liver transplantation. Tumor tissue contained messenger RNA for insulin-like growth factor-II (IGF-II), and circulating high molecular weight components and E-peptide of IGF-II were increased. Glucose use measured by isotope dilution with [3-3H]glucose was 7.94 mg/kg fat-free mass per min, and splanchnic glucose production was 0.93 mg/kg fat-free mass per min. Glucose uptake and glucose model parameters were independently measured in tissues by positron emission tomography with 18F-fluoro-2-deoxy-D-glucose. Glucose uptake by heart muscle, liver, skeletal muscle, and neoplasm accounted for 0.8, 14, 44, and 15% of total glucose use, respectively. Model parameters in liver and neoplasm were not significantly different, and glucose transport and phosphorylation were twofold and fourfold greater than in muscle. This suggests that circulating IGF-II-like proteins are partial insulin agonists, and that hypoglycemia in hepatoma with IGF-II production is predominantly due to glucose uptake by skeletal muscle and suppression of glucose production.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DeFronzo, R. A., Jacot, E., Jequier, E., Maeder, E., Wahren, J., & Felber, J. P. (1981) · Diabetes · doi:10.2337/diab.30.12.1000 · Cited by 1,770
Patlak, C. S., & Blasberg, R. G. (1985) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1985.87 · Cited by 1,673
RIZZA, R. A., MANDARINO, L. J., & GERICH, J. E. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-54-1-131 · Cited by 696 · cited 1×
“an agent that produces insulin resistance at the postreceptor level (53).”
BackgroundInsulin Control of Glucose Metabolism in Man
Insel, P. A., Liljenquist, J. E., Tobin, J. D., Sherwin, R. S., Watkins, P., Andres, R., & Berman, M. (1975) · Journal of Clinical Investigation · doi:10.1172/jci108006 · Cited by 244
MACGORMAN, L. R., RIZZA, R. A., & GERICH, J. E. (1981) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-53-3-556 · Cited by 175 · cited 1×
“due to circulating IGF-related peptides, although GH deficiency and subnormal glucagon response to hypoglycemia may have been contributing factors (49).”
Background
Cited by
Diagnosis and Treatment of Hepatocellular Carcinoma
El-Serag, H. B., Marrero, J. A., Rudolph, L., & Reddy, K. R. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.02.090 · Cited by 1,137
Le Roith, D. (1997) · New England Journal of Medicine · doi:10.1056/nejm199702273360907 · Cited by 897
Livingstone, C. (2013) · Endocrine-Related Cancer · doi:10.1530/erc-13-0231 · Cited by 296
The Role of the Insulin-like Growth Factor System in Human Cancer
(1996) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60354-1 · Cited by 293
Guide for diagnosis and treatment of hepatocellular carcinoma
Attwa, M. H. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i12.1632 · Cited by 242
Metadata
- Authors
- Eastman, R. C., Carson, R. E., Orloff, D. G., Cochran, C. S., Perdue, J. F., Rechler, M. M., Lanau, F., Roberts, C. T., Shapiro, J., & Roth, J.
- Venue
- Journal of Clinical Investigation
- Published
- 1992-06-01
- Volume
- 89
- Issue
- 6
- Pages
- 1958-1963
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2012851855
- Cited by
- 68
- References
- 5
- FWCI
- 2.76
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Glucose utilization in a patient with hepatoma and hypoglycemia. Assessment by a positron emission tomography. https://app.cochat.ai/papers/10.1172/jci115803
- The paper
- Eastman, R. C., Carson, R. E., Orloff, D. G., Cochran, C. S., Perdue, J. F., Rechler, M. M., Lanau, F., Roberts, C. T., Shapiro, J., & Roth, J. (1992). Glucose utilization in a patient with hepatoma and hypoglycemia. Assessment by a positron emission tomography. Journal of Clinical Investigation. https://doi.org/10.1172/jci115803
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.